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ost-Operative
trial Fibrillation
nd Oxidative Stress
Novel Causal Mechanism or
nother Biochemical Epiphenomenon?*
akan Oral, MD, FACC
nn Arbor, Michigan
ver the last decade there has been substantial progress in
nderstanding the pathogenesis of atrial fibrillation (AF),
rimarily due to the recognition of the role of the pulmonary
eins and their antral regions in the initiation and perpet-
ation of AF (1,2). Much work has focused on the electro-
hysiological (3,4), anatomical, and histological properties
f the pulmonary veins (5); how they initiate and perpetuate
F; and also on the potential role of the left atrium in the
erpetuation of AF (6–8). However, little is known about
hy and how pulmonary veins (and/or the left atrium)
ecome arrhythmogenic in some patients and remain dor-
ant in others. It also is not clear whether the pulmonary
eins are electroanatomically different in patients with AF
han in normal subjects. For example, in one study the
ffective refractory period within the pulmonary veins was
ound to be shorter in patients with than without AF (3),
hereas in another study no significant difference was
bserved (4).
See page 68
Isoproterenol, adenosine, acetylcholine, parasympathetic
timulation, and rapid atrial pacing have been used to promote
F both in vitro and in vivo. It is possible that neurohormonal
ctivation, changes in parasympathetic/sympathetic tone,
tretch, and proinflammatory cytokines facilitate AF, specifi-
ally in the presence of a genetic and/or acquired predisposition
uch as certain channelopathies; genetic polymorphisms;
hanges in gap junctions; and/or extracellular matrix with
brosis, stretch, and left atrial dilatation, etc.
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Division of Cardiovascular Medicine, University of Michigan, Anno
rbor, Michigan. Dr. Oral is co-founder and stockholder of Ablation Frontiers, Inc.
nd has served as a consultant to Ablation Frontiers, Inc.Post-operative AF may provide a model to better under-
tand at least some of the mechanisms that promote AF. As
idely reported, post-operative AF may develop in up to
5% of patients after cardiac surgery, usually within 2 to 5
ays, and often resolves within several weeks. The majority
f the patients who develop post-operative AF never expe-
ience AF again, suggesting that a set of reversible factors
esulted in AF. A genetic and/or acquired electroanatomical
bnormality of the atrium and/or pulmonary veins may not
ecessarily be sufficient for the development of recurrent AF
n these patients. Moreover, such an electroanatomical
redisposition may not even be necessary for the genesis of
F in these patients.
Increasing age, male gender, history of AF, left atrial
ilatation, low left ventricular ejection fraction, hyperten-
ion, chronic obstructive pulmonary disease, and obesity
ave been identified as predictors of post-operative AF (9).
he technique and complexity of cardiac surgery, and
eri-operative treatment with beta-blockers or antiarrhyth-
ic agents such as amiodarone or sotalol, have also been
emonstrated to influence the probability of post-operative
F (10).
Catecholamines, inflammation, release of proinflamma-
ory cytokines, and activation of tissue oxidases with an
ncrease in oxidative stress have been implicated as potential
echanisms that facilitate post-operative AF. Prior in vitro
tudies have demonstrated that oxidative stress may lead to
lectroanatomical remodeling and increase the vulnerability
o AF by decreasing atrial effective refractory period and by
ltering the extracellular matrix with progressive fibrosis
11,12). Steroids and statins have been shown to attenuate
rofibrillatory effects of oxidative stress.
A few clinical studies have demonstrated the beneficial
ffects of pre-treatment with corticosteroids and statins for the
revention of post-operative AF. A recent randomized study
emonstrated that perioperative treatment with hydrocorti-
one in conjunction with metoprolol was associated with a
ignificant decrease in post-operative AF (13). In another
andomized study, pre-operative therapy with atorvastatin
as associated with a 61% reduction in the risk of post-
perative AF (14).
In this issue of the Journal, Kim et al. (15) report on the
ssociation between nicotinamide adenine dinucleotide
hosphate (NADPH) oxidase activity in the human atrium
nd the development of AF after cardiac surgery. In this
tudy, the authors measured basal and NADPH-stimulated
uperoxide production in the right atrial appendage samples
btained from 170 consecutive patients who underwent
oronary artery bypass surgery. The authors also measured
lasma markers of lipid and protein oxidation.
Patients who developed post-operative AF were found to
ave a significant increase in atrial NADPH oxidase
ctivity. Although reperfusion during surgery was associated
ith an increase in plasma markers of lipid and protein
xidation, this increase was not associated with the devel-
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Editorial Comment January 1/8, 2008:75–6pment of post-operative AF. On multivariate analysis, an
ncrease in NADPH oxidase activity was identified as the
trongest independent predictor of post-operative AF.
ased on these observations, the authors propose that the
trial NADPH oxidase system may be a critical pathway in
he development of post-operative AF. This report is a
atural follow-up of a series of previous studies by the
uthors. They first demonstrated the presence of NADPH
xidase in human atrial myocytes, and then found increased
evels of this oxidase system in patients with paroxysmal or
hronic AF.
The premise of the study is that plasma markers of oxidative
tress may not have sufficient specificity to accurately reflect
hanges that occur in the human atrium, particularly when
obust activation of a number of oxidases may occur in the
ourse of cardiac surgery. Therefore, the authors measured
oth plasma markers of oxidation and tissue oxidase activity.
he study demonstrates that there is no association between
yocardial oxidase activity and plasma markers of oxidation
nd also no association between the plasma markers and the
robability of post-operative AF.
On multivariate analysis that included the variables of
ge, diabetes, post-operative therapy with beta-blockers,
reatment with angiotensin-converting enzyme inhibitors or
ngiotensin receptor blockers, or statins, and NADPH-
timulated superoxide levels, oxidase activity was the only
ndependent predictor of AF.
The authors should be commended for meticulously
onducting experiments in a large number of samples of
uman cardiac tissue. Demonstrating the role that atrial
xidases may play in the genesis of AF in the human heart
ith a large sample size and recognizing the need to study
otential mechanisms at the tissue level rather than assess-
ng systemic parameters are the major strengths of this
mportant study.
However, the findings of this study are hypothesis-
enerating instead of conclusive and should be carefully
nterpreted. First, this study demonstrates an association
etween oxidase activity in the atrium and the development
f post-operative AF. Causality is not demonstrated by
hese findings. It is possible that NADPH oxidase activity is
ne of the many biochemical changes that occur during the
evelopment of post-operative AF and is not the primary
ausal event. When complex interactions between the
eurohormonal system, proinflammatory cytokines, and
xidative stress are considered, it may be quite difficult to
issect the primary biochemical abnormality. Nicotinamide
denine dinucleotide phosphate oxidase may simply be a
urrogate for one or more of the complex changes that occur
uring and after cardiopulmonary bypass and cardiac
urgery.
It should also be noted that left atrial size was not
ncluded in the multivariate analysis, due to the unavail-
bility of these data. Although it did not appear to be an
ndependent predictor, age was closely associated with an
ncrease in oxidase activity and development of post-perative AF, raising the possibility that an increase in
xidase activity may be one of the mechanisms by which
ging may facilitate AF.
Despite the descriptive nature of the findings, the study
rovides another piece of information in the quest to better
nderstand mechanisms of AF and devise therapeutic strat-
gies. These observations may not be limited to post-
perative AF, but may also point to potential biochemical
ediators that activate mechanisms involved in the genesis
f other types of AF. These initial observations hopefully
ill prompt additional studies to further investigate the
pecific pathways involved in the initiation and perpetuation
f AF.
eprint requests and correspondence: Dr. Hakan Oral, Cardio-
ascular Center, Room 2556, 1500 East Medical Center Drive,
nn Arbor, Michigan 48109. E-mail: oralh@umich.edu.
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